Endocyte, Inc. (NASDAQ: ECYT) announced today that it intends to offer and sell $175.0 million of its common stock in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE